(1)Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimuspharmacokinetics in renal transplant patients.1 B6 l% B+ [; S" j( w
(2)The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese Han patients with coronary heart disease. 6 Z3 n9 v9 H! T" P1 \+ A; ?(3)CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients